Clearmind Medicine Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions CAD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Clearmind Medicine Inc. (CMND) - Annual data in millions CAD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingOct 2025Oct 2024Oct 2023Oct 2022Oct 2021Oct 2020
Current Assets
Cash and Cash Equivalents3.926.575.430.133.710.25
Short-Term Investments1.660.290.090.190.000.00
Cash & Short-Term Investments5.596.865.510.323.710.25
Accounts Receivable0.320.180.240.100.160.00
Inventory0.000.000.000.000.000.00
Other Current Assets0.040.040.040.010.130.00
Total Current Assets5.957.095.790.433.970.25
Non-Current Assets
Property, Plant & Equipment (Net)0.020.050.000.050.020.00
Intangible Assets0.100.110.120.130.160.00
Other Non-Current Assets0.020.010.040.010.020.00
Total Non-Current Assets0.140.170.160.390.190.00
Total Assets6.087.265.950.834.160.25
Current Liabilities
Accounts Payable0.680.530.621.400.280.00
Short-Term Debt1.760.000.000.000.000.00
Current Portion of Long-Term Debt1.760.000.000.000.000.00
Accrued Liabilities0.060.050.040.210.010.01
Other Current Liabilities2.373.524.310.290.000.00
Total Current Liabilities4.894.134.971.930.290.01
Non-Current Liabilities
Long-Term Debt0.000.020.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.000.00
Total Non-Current Liabilities0.000.020.000.000.000.00
Total Liabilities4.894.154.971.930.290.01
Stockholders' Equity
Common Stock26.4024.1717.136.716.380.67
Retained Earnings-27.88-24.02-18.77-10.15-3.58-0.54
Accumulated Other Comprehensive Income-0.022.962.622.331.080.11
Shares Outstanding0.160.110.020.000.000.00
Total Stockholders' Equity1.193.110.98-1.113.870.24
Total Liabilities & Equity6.087.265.950.834.160.00